TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
The activation and fusion of macrophages and of osteoclasts require the adaptor molecule DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based activation motifs (ITAMs). TREM2 (triggering receptor expressed on myeloid cells-2) is the main DAP12-associated receptor in osteoclasts and, similar to DAP12 deficiency, loss of TREM2 in humans leads to Nasu-Hakola disease, which is characterized by bone cysts and dementia. Furthermore, in vitro experiments have shown that deficiency in DAP12 or TREM2 leads to impaired osteoclast development and the formation of mononuclear osteoclasts. Here, we demonstrate that the ligation of TREM2 activated phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase 1 (ERK1) and ERK2, and the guanine nucleotide exchange factor Vav3; induced the mobilization of intracellular calcium (Ca(2+)) and the reorganization of actin; and prevented apoptosis. The signaling adaptor molecule DAP10 played a key role in the TREM2- and DAP12-dependent recruitment of PI3K to the signaling complex. Src homology 2 (SH2) domain-containing inositol phosphatase-1 (SHIP1) inhibited TREM2- and DAP12-induced signaling by binding to DAP12 in an SH2 domain-dependent manner and preventing the recruitment of PI3K to DAP12. These results demonstrate a previously uncharacterized interaction of SHIP1 with DAP12 that functionally limits TREM2- and DAP12-dependent signaling and identify a mechanism through which SHIP1 regulates key ITAM-containing receptors by directly blocking the binding and activation of PI3K.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, SHIP1 inhibits phagocytic signal transduction by triggering receptor expressed on myeloid cells 2 (TREM2) and tyrosine kinase binding protein (TYROBP, also known as DAP12).11”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D inhibits triggering receptor expressed on myeloid cell 2 (TREM2) signaling by sterically blocking the site where tyrosine-protein kinase (SYK) binds to tyrosine kinase-binding protein (TYROBP), the TREM2 adaptor protein, 10”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“INPP5D negatively regulates signaling via several microglial cell surface receptors, including triggering receptor expressed on myeloid cells 2 (TREM2)”
From INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease (2023) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies support the hypothesis that SHIP1 negatively regulates microglia and macrophage phagocytosis, likely through its proposed regulation of TREM2 and TLR4, as well as Fc gamma receptor (FCγR) and complement receptor 3 (CR3)-mediated signaling, and potentially of other signaling pathways [106, 114, 121, 134–138].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is an activating receptor of the Ig-superfamily that binds lipids and transmits intracellular signals through the adaptor DAP12 (Peng et al., 2010; Ulland et al., 2017).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Peng et al., 2010
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 828
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
Mócsai, A., Humphrey, M. B., Van Ziffle, J. A. G., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A., & Nakamura, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401602101 · Cited by 463
Self-citationHamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Self-citationNKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway
Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., & Leibson, P. J. (2003) · Nature Immunology · doi:10.1038/ni929 · Cited by 374
Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation
Pasquier, B., Launay, P., Kanamaru, Y., Moura, I. C., Pfirsch, S., Ruffié, C., Hénin, D., Benhamou, M., Pretolani, M., Blank, U., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.017 · Cited by 346
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice
Kaifu, T., Nakahara, J., Inui, M., Mishima, K., Momiyama, T., Kaji, M., Sugahara, A., Koito, H., Ujike-Asai, A., Nakamura, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16923 · Cited by 343
DAP10‐ and DAP12‐associated receptors in innate immunity
Lanier, L. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00720.x · Cited by 323
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318
Research works printed but not linked: 1
- 10.4049/jimmunol.177.6.3520 · DOI · Paper page
Cited by
Items 201–300 of 447
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Blunt, M. D., & Ward, S. G. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.015 · Cited by 29
Adapala, N. S., Barbe, M. F., Tsygankov, A. Y., Lorenzo, J. A., & Sanjay, A. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24779 · Cited by 29
TREM2 in MASH: integrating lipid metabolism and immune response
Shi, S., Zhou, Y. Y., Zhang, H., & Zhang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604837 · Cited by 28
Xie, X., Hu, L., Mi, B., Panayi, A. C., Xue, H., Hu, Y., Liu, G., Chen, L., Yan, C., Zha, K., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.826023 · Cited by 28
Molecular Regulation Mechanism of Microglial Autophagy in the Pathology of Alzheimer's Disease
Ou-Yang, P., Cai, Z., & Zhang, Z.-H. (2023) · Aging and Disease · doi:10.14336/ad.2023.0106 · Cited by 28
Iyer, S., Viernes, D. R., Chisholm, J. D., Margulies, B. S., & Kerr, W. G. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0122 · Cited by 29
Self-citationHall, S. C., & Agrawal, D. K. (2016) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1133303 · Cited by 28
CD19-positive antibody-secreting cells provide immune memory
Groves, C. J., Carrell, J. A., Grady, R., Rajan, B., Morehouse, C. A., Halpin, R., Wang, J., Wu, J., Shrestha, Y., Rayanki, R., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017015172 · Cited by 28
Zhu, B., Feng, J., Liang, X., Fu, Z., Liao, M., Deng, T., Wang, K., Xie, J., Chi, J., Yang, L., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02538-1 · Cited by 27
Rosner, D., Sun, J., Cacace, R., Yee, A., Wagh, C., Rychkova, A., Dunlap, M., Gulbranson, D. R., Ibrahim, A., Wang, X., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.11.022 · Cited by 28
Immune-Related Hub Genes and the Competitive Endogenous RNA Network in Alzheimer’s Disease
Xu, H., & Jia, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200081 · Cited by 27
Zhu, Y., Zhao, Y., Lu, Y., Fang, C., Zhang, Q., Zhang, J., Ju, Z., Zhang, Y., Xu, T., & Zhong, C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.011 · Cited by 27
Brain resident microglia in Alzheimer’s disease: foe or friends
Kaur, S., Malleshwari, K., Sharma, A., Giridharan, V. V., & Dandekar, M. P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01550-8 · Cited by 27
Manno, B., Oellerich, T., Schnyder, T., Corso, J., Lösing, M., Neumann, K., Urlaub, H., Batista, F. D., Engelke, M., & Wienands, J. (2016) · European Journal of Immunology · doi:10.1002/eji.201646431 · Cited by 27
Ji, K.-Y., Kim, S., Yee, S., Kim, M., Ban, Y.-J., Kim, E., Lee, E. H., Choi, H., Yun, H., Lee, C. W., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002325rr · Cited by 27
Pedicone, C., Fernandes, S., Matera, A., Meyer, S. T., Loh, S., Ha, J.-H., Bernard, D., Chisholm, J. D., Paolicelli, R. C., & Kerr, W. G. (2022) · iScience · doi:10.1016/j.isci.2022.104170 · Cited by 26
Self-citationTangavelou, K., & Bhaskar, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212335 · Cited by 25
Zhao, Y., Guo, Q., Tian, J., Liu, W., & Wang, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102596 · Cited by 26
Microglial and TREM2 dialogues in the developing brain
Morini, R., Tagliatti, E., Bizzotto, M., & Matteoli, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.022 · Cited by 25
TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 25
Alzheimer’s Disease Genetics: A Dampened Microglial Response?
Chatila, Z. K., & Bradshaw, E. M. (2021) · The Neuroscientist · doi:10.1177/10738584211024531 · Cited by 25
Myeloid checkpoints for cancer immunotherapy
Qian, Y., Yang, T., Liang, H., & Deng, M. (2022) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2022.05.07 · Cited by 25
Current understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 25
Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2
Bradshaw, W. J., Kennedy, E. C., Moreira, T., Smith, L. A., Chalk, R., Katis, V. L., Benesch, J. L. P., Brennan, P. E., Murphy, E. J., & Gileadi, O. (2024) · Structure · doi:10.1016/j.str.2024.01.005 · Cited by 24
Basha, S. C., Ramaiah, M. J., & Rao, K. S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221070 · Cited by 24
Zhou, X., Song, H., He, J., Han, W., & Li, Q. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13228 · Cited by 24
Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke
Zhu, Z., Li, Z., Li, Y., Huang, T., Chao, Y.-C., Pan, L., Zhu, H. F., Zhao, Y., Yu, W., & Li, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00758 · Cited by 24
Samuels, J. D., Lukens, J. R., & Price, R. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15981 · Cited by 23
An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain
Shaw, B. C., Snider, H. C., Turner, A. K., Zajac, D. J., Simpson, J. F., & Estus, S. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215602 · Cited by 23
Varnum, M. M., Clayton, K. A., Yoshii-Kitahara, A., Yonemoto, G., Koro, L., Ikezu, S., & Ikezu, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759159 · Cited by 22
Zhang, Y., Liu, J., Luo, S., Liang, H., Guo, C., Du, Y., Li, H., Wang, L., Wang, X., Tang, C., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70252 · Cited by 22
Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer
Elfstrum, A. K., Bapat, A. S., & Schwertfeger, K. L. (2024) · Cancer Medicine · doi:10.1002/cam4.7053 · Cited by 22
Blunt, M. D., & Ward, S. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00226 · Cited by 22
Thankam, F. G., Dilisio, M. F., Dougherty, K. A., Dietz, N. E., & Agrawal, D. K. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1196138 · Cited by 22
Houle, S., & Kokiko‐Cochran, O. N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.788055 · Cited by 22
The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke
Ma, W.-Y., Wang, S., Wu, Q.-L., Zhou, X., Chu, S., & Chen, N. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108733 · Cited by 22
Wei, P., Lü, Q., Cui, G., Guan, Z., Li, Y., Sun, C., Sun, W., & Peng, Q. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.12.007 · Cited by 22
Self-citationPathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
The various roles of TREM2 in cardiovascular disease
Wang, S., Cao, C., & Peng, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1462508 · Cited by 21
TREM2 variants that cause early dementia and increase Alzheimer’s disease risk affect gene splicing
Kiianitsa, K., Lukes, M. E., Hayes, B. J., Brutman, J. N., Valdmanis, P. N., Bird, T. D., Raskind, W. H., & Korvatska, O. (2024) · Brain · doi:10.1093/brain/awae014 · Cited by 21
Function and mechanism of TREM2 in bacterial infection
Wu, Z., Yang, S., Fang, X., Shu, Q., & Chen, Q. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011895 · Cited by 21
TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma
Wang, Q., Zheng, K., Tan, D., & Liang, G. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.079 · Cited by 22
Tampella, G., Kerns, H. M. M., Niu, D., Singh, S., Khim, S., Bosch, K. A., Garrett, M. E., Moguche, A. O., Evans, E. K., Browning, B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403238 · Cited by 21
Regulation of disease-associated microglia in the optic nerve by lipoxin B4 and ocular hypertension
Maurya, S., Lin, M., Karnam, S., Singh, T., Kumar, M., Ward, E., Sivak, J. M., Flanagan, J. G., & Gronert, K. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00775-z · Cited by 20
TREM2 in cardiovascular diseases: Mechanisms and therapeutic perspectives
Zhu, W., Yue, Z., Wang, Y., Guo, L., & Liu, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102774 · Cited by 20
Molecular signaling in biomaterial-induced foreign body response: current perspectives
Rahaman, S. G., Khan, M. I., Sankaran, K. R., & Rahaman, S. O. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00595.2025 · Cited by 20
INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer’s Disease Pathophysiology
Olufunmilayo, E. O., & Holsinger, R. M. D. (2023) · Genes · doi:10.3390/genes14101845 · Cited by 20
Therapeutic targeting of tumor-associated macrophages
Rasmussen, R. K., & Etzerodt, A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.002 · Cited by 20
Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia
Wißfeld, J., Mathews, M., Mossad, O., Picardi, P., Cinti, A., Redaelli, L., Pradier, L., Brüstle, O., & Neumann, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-92434-2 · Cited by 20
Nigorikawa, K., Hazeki, K., Sasaki, J., Omori, Y., Miyake, M., Morioka, S., Guo, Y., Sasaki, T., & Hazeki, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142091 · Cited by 20
Pauls, S. D., Ray, A., Hou, S., Vaughan, A. T., Cragg, M. S., & Marshall, A. J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600105 · Cited by 20
PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology
Messenger, E. J., Baar, S. A., Bedford, L. M., Tsai, A. P., Lin, P. B., Ferguson, C. A., Xu, G., Wallace, A., Landreth, G. E., Lamb, B. T., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70231 · Cited by 19
“32,33,35,43,58,59 21 To clarify the role of the TREM2–PLCG2 axis among these pathways in AD, we dissected the DEGs identified by bulk RNA-seq.”
Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
Yu, T., Yu, S.-K., Xiang, Y., Lu, K., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936496 · Cited by 20
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 20
Regulation of TREM2 on BV2 inflammation through PI3K/AKT/mTOR pathway
Li, L., Chen, Q., Qin, Y., Yu, G., Qi, T., Sui, H., Qi, X., & Huang, L. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2204719 · Cited by 19
Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing
Zhu, X., Zhang, C., Jiang, W., Zeng, Z., Zhang, K., Du, M., Chen, J., Wu, Q., Liao, W., Chen, Y., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70026 · Cited by 19
Wei, W., Qu, Z.-L., Li, L., & Zhang, P. (2024) · Current Medical Science · doi:10.1007/s11596-024-2946-3 · Cited by 19
Zajac, D. J., Simpson, J., Zhang, E., Parikh, I., & Estus, S. (2023) · Genes · doi:10.3390/genes14030763 · Cited by 18
“In addition to the negative regulation of PI3K action, SHIP1 also inhibits Syk by competing for its binding to phosphorylated DAP12 [17].”
BackgroundInfluentialNguyen, N.-Y. N., Maxwell, M. J., Ooms, L. M., Davies, E. M., Hilton, A. A., Collinge, J. E., Hilton, D. J., Kile, B. T., Mitchell, C. A., Hibbs, M. L., et al. (2011) · Blood · doi:10.1182/blood-2011-01-331041 · Cited by 19
Yao, Y., Xie, S., & Wang, F. (2018) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2018.12.002 · Cited by 18
SHIP inhibition mediates select TREM2-induced microglial functions
Ramakrishnan, G. S., Berry, W. L., Pacherille, A., Kerr, W. G., Chisholm, J. D., Pedicone, C., & Humphrey, M. B. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.04.002 · Cited by 17
Self-citationAs48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition
Cho, S., Gaamouch, F. E., Upadhyay, S., Nada, H., Kuncewicz, K., & Gabr, M. T. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118862 · Cited by 17
Connor, S. M., Rashid, M., Ryan, K. J., Patel, K. R., Boyd, J. D., Smith, J., Elyaman, W., Bennett, D. A., & Bradshaw, E. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.894601 · Cited by 17
Wieczorek, K., Markiewicz, M., Walczewska, A., & Zgórzyńska, E. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000668 · Cited by 17
Mishra, S., Swain, P. S., Pati, S., & Dehury, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41414 · Cited by 17
Jesudason, C. D., Mason, E. R., Chu, S., Oblak, A. L., Javens‐Wolfe, J., Moussaif, M., Durst, G., Hipskind, P. A., Beck, D. E., Dong, J., et al. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12429 · Cited by 16
Microglial Dysfunction in Autism Spectrum Disorder
Meng, J., Zhang, L., & Zhang, Y. (2024) · The Neuroscientist · doi:10.1177/10738584241252576 · Cited by 16
Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer’s and related dementias
Yin, T., Yesiltepe, M., & D’Adamio, L. (2024) · EMBO Reports · doi:10.1038/s44319-024-00077-x · Cited by 15
Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases
Dong, X., Zhao, X., Gao, J., Bo, L., Li, Y., Kong, Z., 孙维绎, Xu, X., Liu, Z., Xiu, Q., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102580 · Cited by 15
The triggering receptor expressed on myeloid cells 2–apolipoprotein E signaling pathway in diseases
Lyu, S., Lan, Z., & Li, C. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002167 · Cited by 15
Arsenault, R., Marshall, S., Salois, P., Li, Q., & Zhang, W. (2024) · Biology · doi:10.3390/biology13020087 · Cited by 16
Sambandam, Y., Sundaram, K., Saigusa, T., Balasubramanian, S., & Reddy, S. V. (2017) · Bone · doi:10.1016/j.bone.2017.05.013 · Cited by 15
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 16
Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy
Soni, D. M., Lin, P. B., Lee‐Gosselin, A., Lloyd, C. D., Mason, E., Ingraham, C. M., Perkins, A., Moutinho, M., Lamb, B. T., Chu, S., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14078 · Cited by 14
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Yeoh, W. J., & Krebs, P. (2023) · European Journal of Immunology · doi:10.1002/eji.202350446 · Cited by 14
Huang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 17
Jiahuan, X., Ying, Z., Hongyu, J., Wei, Z., Guan, S., Chengyue, D., Liangyu, F., Fan, L., & Wang, W. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.843828 · Cited by 14
Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
TREM-2: friend or foe in infectious diseases?
Matos, A. D. O., Dantas, P. H. D. S., Queiroz, H. A. G. D. B., Silva‐Sales, M., & Sales‐Campos, H. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2146481 · Cited by 14
The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
Liu, G., Zhang, L., Fan, Y., & Ji, W. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206150 · Cited by 14
Role of SHIP1 in Invariant NKT Cell Development and Functions
Anderson, C., Salter, A. I., Toussaint, L. E., Reilly, E. C., Fugère, C., Srivastava, N., Kerr, W. G., & Brossay, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500567 · Cited by 14
Self-citationTREM2 in Regulating Macrophage Inflammatory Responses and Disease Pathogenesis
Medd, M. M. (2024) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2024054889 · Cited by 14
Unveiling the impact of TREM-2+ Macrophages in metabolic disorders
Contreras, M., Matos, A. D. O., Dantas, P. H. D. S., Neto, J. R. D. C., Silva‐Sales, M., & Sales‐Campos, H. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104882 · Cited by 13
Peng, X., Yang, Z., Guo, H.-S., Wu, X., Ruganzu, J. B., Liu, Z., Wu, S., & Yang, W. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05449-5 · Cited by 13
Gao, H., Yang, Z., Sun, H., Zhang, Y., Wang, Z., Liu, W., Wen, H., Qu, C., & Wang, X. (2023) · PubMed Central · Cited by 13
Advances in proteomic phenotyping of microglia in neurodegeneration
Sunna, S. N., Bowen, C. A., Ramelow, C. C., Santiago, J. V., Kumar, P., & Rangaraju, S. (2023) · PROTEOMICS · doi:10.1002/pmic.202200183 · Cited by 13
Therapeutic targeting of tumour-associated macrophage receptors
Martins, R. G. A., Tekin, M. M., Cragg, M. S., & Roghanian, A. (2024) · Immunotherapy Advances · doi:10.1093/immadv/ltaf009 · Cited by 11
Glycolytic metabolism supports microglia training during age-related neurodegeneration
Camacho‐Morales, A. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00363-2 · Cited by 11
SHIP1 is required for the formation of neutrophil extracellular traps in rheumatoid arthritis
Cheng, Z., Xia, N., Chen, Z., Li, M., Tang, Z., Wu, H., Yan, X., Wang, Y., Wang, Y., Tang, X., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109625 · Cited by 11
Bandow, K., Hasegawa, H., Tomomura, M., & Tomomura, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.045 · Cited by 11
Pei, Q., Wang, H., Lin, L., & Wang, Z. (2021) · Oral Diseases · doi:10.1111/odi.14004 · Cited by 10
Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation
Zhao, C., Qi, W., Lv, X., Gao, X., Liu, C., & Zheng, S. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70338 · Cited by 10
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
Lee, H.-Y., Lee, E., Yi, J., Ji, K.-Y., Kim, S., Choi, H.-R., Yee, S., Kang, H., & Kim, E. (2021) · BMC Immunology · doi:10.1186/s12865-021-00420-0 · Cited by 10
DAP12 Overexpression Induces Osteopenia and Impaired Early Hematopoiesis
Despars, G., Pandruvada, S. N. M., Anginot, A., Domenget, C., Jurdic, P., & Mazzorana, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065297 · Cited by 10
Cardona, C. L., Wei, L., Kim, J., Angeles, E., Singh, G., Chen, S., Patel, R., Ifediora, N., Canoll, P., Teich, A. F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03562-9 · Cited by 11
Zhou, X., Liu, Z., Li, S., Song, Y., Sun, M., Si, Z., & Zhu, W. (2025) · Inflammation Research · doi:10.1007/s00011-025-02155-9 · Cited by 9
Tang, S., Xing, W., Yan, J., Wang, L., Zhao, L., Wang, Y., Gu, N., & Sun, X. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149235 · Cited by 9
Bandow, K., Smith, A., & Garlick, J. A. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.048 · Cited by 9
INPP5D/SHIP1 regulates inflammasome activation in human microglia
Chou, V., Fancher, S. B., Pearse, R. V., Lee, H., Lam, M., Seyfried, N. T., Bennett, D. A., De Jager, P. L., Menon, V., & Young-Pearse, T. L. (2023) · doi:10.1101/2023.02.25.530025 · Cited by 8
Metadata
- Authors
- Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., & Humphrey, M. B.
- Affiliations
- Jilin University (CN)
- University of Oklahoma Health Sciences Center (US)
- University of California, San Francisco (US)
- SUNY Upstate Medical University (US)
- Oklahoma Medical Research Foundation (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Humphrey, Mary Beth
- Venue
- Science Signaling
- Published
- 2010-05-18
- Volume
- 3
- Issue
- 122
- Pages
- ra38-ra38
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC2900152
- OpenAlex
- W2121590561
- Cited by
- 413
- References
- 55
- Citations by year
- 2026: 41 · 2025: 43 · 2024: 49 · 2023: 44 · 2022: 41 · 2021: 34 · 2020: 28 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 11 · 2015: 13 · 2014: 14 · 2013: 11 · 2012: 14
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL085580, R01HL085580, R01HL072523, HL72523)
- National Institute of Allergy and Infectious Diseases (U19AI062629)
- National Institute of Dental and Craniofacial Research (DE019398, R01DE019398)
- National Center for Research Resources (P20RR020143, P20 RR0201143)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- TREM2, DAP12, DAP10, SHIP1, PI3K activation, osteoclastogenesis, macrophage fusion, ERK signaling, Vav3, calcium mobilization, actin reorganization, apoptosis, Nasu-Hakola disease, SH2 domain binding, receptor signaling regulation
- MeSH terms
- Inositol Polyphosphate 5-Phosphatases, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Phosphoinositide-3 Kinase Inhibitors, Animals, Cell Division, Cell Line, Enzyme Activation, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Phosphoric Monoester Hydrolases, Phosphorylation, Receptors, Immunologic, Signal Transduction, src Homology Domains, Phosphatidylinositol 3-Kinases, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.